Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nihon Techno Service Co. Ltd. is currently addressing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution activity is confined to a distinct examiner and a distinct art unit. The narrow scope of current activity reflects a singular point of contact within the patent office for the company's pending matters. This concentrated focus suggests that the company's current intellectual property efforts are directed toward a specific technical innovation within this sector.
BAUSCH, SARAE L is the busiest examiner for the portfolio, who is responsible for 1 pending office action. This individual handles the only active matter currently pending for the company. Because there is a distinct art unit involved, the prosecution is centralized within a specific technical examination group. This singular point of contact simplifies the administrative tracking of the company's patent applications. Practitioners can observe that the workload is not distributed across multiple personnel or administrative divisions at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAUSCH, SARAE L | 1 | 29.7% | +45.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18685768 | QUANTITATIVE PCR METHOD USING INTERNAL CONTROL | BAUSCH, SARAE L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18685768 | QUANTITATIVE PCR METHOD USING INTERNAL CONTROL | BAUSCH, SARAE L | — |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18685768 | QUANTITATIVE PCR METHOD USING INTERNAL CONTROL | BAUSCH, SARAE L | 1699 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNihon Techno Service Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sarae L Bausch has the most, with 1 of Nihon Techno Service Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
